glofitamab and obinutuzumab in r/r mcl
Published 2 years ago • 353 plays • Length 5:44Download video MP4
Download video MP3
Similar videos
-
2:04
the starglo trial: glofitamab in combination with gemcitabine and oxaliplatin in r/r dlbcl
-
1:45
a phase i/ii trial of glofitamab monotherapy in r/r mcl
-
1:17
globryte: investigating glofitamab monotherapy in patients with r/r mcl
-
2:18
update on phase i/ii study of glofitamab monotherapy in r/r mcl
-
2:40
phase ii study of glofitamab in patients with r/r lbcl
-
1:00
updates on glofitamab in mcl
-
2:21
impact of tmtv on pfs following glofitamab treatment in r/r dlbcl
-
3:58
extended follow-up of glofitamab monotherapy in r/r lbcl: durability of cr and likelihood of crs
-
1:19:44
[hema-2] overview of hemostasis and platelets
-
29:38
dlbcl treatment approaches: what you need to know
-
3:36
how can i ensure my cll doesn’t progress to richter’s transformation?
-
2:43
insights into phase i/ii study assessing fixed-duration glofitamab treatment for r/r lbcl
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:21
cd20/cd3 bispecific antibodies in r/r dlbcl: glofitamab and epcoritamab
-
5:46
glofitamab and polatuzumab vedotin in dlbcl
-
1:58
ash highlights: glofitamab in dlbcl & pirtobrutinib and epcoritamab in richter's transformation
-
2:23
zilo-301: phase iii study of zilovertamab ibrutinib vs ibrutinib in r/r mcl
-
2:54
updated results of glofitamab plus polatuzumab vedotin combination therapy in dlbcl, including hgbcl
-
2:00
glofitamab: a valuable agent for the treatment of patients with r/r mantle cell lymphoma
-
5:30
glofitamab in r/r dlbcl: updated safety and efficacy data
-
1:26
bispecifics in nhl: epcoritamab and glofitamab
-
5:06
trials of interest in the mantle cell lymphoma space at ash 2023